3. For whom we create added value
In this chapter, we first look at the added value the innovative biopharmaceutical sector creates for patients, the healthcare system, and society through the new medicines and vaccines it develops and brings to market. we have selected four striking examples and also examine the importance of value-based pricing for these innovations.
Our sector is also a cornerstone of Belgium’s knowledge economy, as shown by the strong figures on employment, exports, production, added value, and investment in 2024. this is further illustrated by the positive cost–benefit analysis of our sector for the Belgian government.
GREGORY HAS A PASSION FOR PHARMA:
EVERY EFFECTIVE MEDICINE IS AN INVESTMENT IN HEALTH - AND IN SOCIETY!
Of course, a medicine relieves pain, treats a disease and sometimes saves lives, but its value goes much further. Thanks to innovation and the most advanced treatments, some patients are not only helped; they also regain part of what the disease has taken from them.
That may mean they can return to work, resume their social life, or need to visit the hospital or doctor less often. In other words: the value of a medicine is not limited to the therapeutic effect. It also has social, human and even economic value.